當(dāng)前位置: 首頁(yè) - 產(chǎn)品目錄 - 小分子抑制劑
Cyclopamine (1-Deoxojervine) 環(huán)巴胺
貨號(hào) | ISH1001 | 售價(jià)(元) | 1512 |
規(guī)格 | 5mg | CAS號(hào) | 4449-51-8 |
- 產(chǎn)品簡(jiǎn)介
- 相關(guān)產(chǎn)品
貨號(hào)
名稱(chēng)
規(guī)格
價(jià)格
ISH1001-0005MG
Cyclopamine (1-Deoxojervine) 環(huán)巴胺
5mg
1512
ISH1001-0010MG
Cyclopamine (1-Deoxojervine) 環(huán)巴胺
10mg
2828
ISH1001-0025MG
Cyclopamine (1-Deoxojervine) 環(huán)巴胺
25mg
5268
產(chǎn)品簡(jiǎn)介:
Cyclopamine 是Hedgehog通路的拮抗劑,細(xì)胞實(shí)驗(yàn)中IC50=46 nM。它還是選擇性Smo抑制劑。
環(huán)巴胺的EC50是10.57微米,這是通過(guò)FXR-bla(法尼基X受體-β-內(nèi)酰胺酶)分析確定的[3]。 Hh信號(hào)通路在胚胎發(fā)育和腫瘤發(fā)生中起著關(guān)鍵作用[4]。Hh信號(hào)通路在廣泛的人類(lèi)組織中顯示出調(diào)節(jié)細(xì)胞增殖和分化的顯著性。它與許多人類(lèi)惡性腫瘤中的異常細(xì)胞存活有關(guān),從基底細(xì)胞癌和髓母細(xì)胞瘤到小細(xì)胞肺、胃腸道、乳腺和前列腺腫瘤[1]。
暴露于環(huán)巴胺的胚胎導(dǎo)致可見(jiàn)的外部缺陷,包括獨(dú)眼畸形、長(zhǎng)鼻形成、小眼癥、胸部前凸、阿米莉亞和體型減小。對(duì)胃腸器官的檢查顯示了嚴(yán)重的缺陷,包括腸管長(zhǎng)度縮短和前腸衍生器官中的間充質(zhì)細(xì)胞數(shù)量減少。在十二指腸、胃和背胰腺中也發(fā)現(xiàn)了異位結(jié)構(gòu)[5]。
產(chǎn)品性質(zhì):
Cas No.:4449-51-8
別名:環(huán)巴胺; 11-Deoxojervine
化學(xué)名: (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethylspiro[2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-ol
Canonical SMILES CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5CC4=C3C)C)O)C)NC1
分子式:C27H41NO2
分子量:411.62
溶解度:≥ 6.9mg/mL in DMSO
儲(chǔ)存條件:Store at -20°C
注意事項(xiàng):
為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。
References:
[1]. Marc J. Meth and Jeffrey M. Weinberg. Cyclopamine: Inhibiting Hedgehog in the Treatment of Psoriasis. Continuing Medical Education, 2006, 78: 185-188.
[2]. Jun Che, Fu-Zheng Zhang, Chao-Qian Zhao, et al. Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti?proliferative, anti?invasive and anti?estrogenic potency in human breast cancer cells. Oncology Letters, 2013, 5: 1417-1421.
[3]. Chia-Wen Hsu, Jinghua Zhao, Ruili Huang, et al. Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor. Scientific Reports, 2014, 4: 6437.
[4]. Robert J. Lipinski, Paul R. Hutson, Paul W. Hannam, et al. Dose- and Route-Dependent Teratogenicity, Toxicity, and Pharmacokinetic Profiles of the Hedgehog Signaling Antagonist Cyclopamine in the Mouse. Toxicological Sciences, 2008, 104(1):189-197.
[5]. Seung K. Kim and Douglas A. Melton. Pancreas development is promoted by cyclopamine, a Hedgehog signaling inhibitor. Proc. Natl. Acad. Sci. USA, 1998, 95: 13036-13041.
- 上一頁(yè): Cyclopamine-KAAD (KAAD-Cyclopamine)環(huán)巴胺-KAAD
- 下一頁(yè): VO-Ohpic trihydrate